002365.SZ · 永安药业
China A-shares · RS rating 63 · As of 2026-10-14
| Price | 12.75 CNY |
|---|---|
| 1-day change | -1.5% |
| RS rating (overall / 1M / 3M / 12M) | 63 / 21 / 93 / 28 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 34 / 16 / 32 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +39.0% |
| Distance from 52-week high | +34.8% |
| Market cap (USD) | $593.6M |